The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: A systematic review

Digestive Diseases and Sciences

Volumn 52, Issue 5, 2007, Pages 1345-1354

  Nurgalieva, Zhannat ^a,b   Lowrey, Angus ^a,b   El Serag, Hashem B ^a,b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Barrett's esophagus; Cardiac; Cytokeratins; Intestinal metaplasia; Markers; Microarray

Indexed keywords

CYTOKERATIN;

BARRETT ESOPHAGUS; CARDIA; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; ENDOSCOPIC BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MATHEMATICAL COMPUTING; MEDICAL LITERATURE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; STATISTICAL ANALYSIS;

BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; CARDIA; DIAGNOSIS, DIFFERENTIAL; GASTRIC FUNDUS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; KERATINS; METAPLASIA; PREDICTIVE VALUE OF TESTS; PYLORIC ANTRUM; SENSITIVITY AND SPECIFICITY; STOMACH; STOMACH DISEASES;

EID: 34247178606     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9399-3     Document Type: Review

References (40)

1. Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287(15):1972-1981
2. Winters C Jr, Spurling TJ, Chobanian SJ, et al. (1987) Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92(1):118-124
3. Sampliner RE (2002) Barrett's esophagus, a complication of GERD. Curr Treat Options Gastroenterol 5(1):45-50
4. El Serag HB (2002) The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 31(2):421-440
5. Bonino JA, Sharma P (2005) Barrett's esophagus. Curr Opin Gastroenterol 21(4):461-465
6. Fitzgerald RC (2005) Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. Clin Gastroenterol Hepatol 3(6):529-537
7. El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM (1999) Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 94(3):622-627
8. Sharma P, Morales TG, Sampliner RE (1998) Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 93(7):1033-1036
9. Goldblum JR (2002) The significance and etiology of intestinal metaplasia of the esophagogastric junction. Ann Diagn Pathol 6(1):67-73
10. Moll R (1997) Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9:63-69
11. Moll R, Franke WW, Schiller D (1982) The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
12. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 30(3):288-294
13. Sarbia M, Donner A, Franke C, Gabbert HE (2004) Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Hum Pathol 35(3):371-376
14. Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, Bakirci N, Tozun N, Sav A (2003) The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable? BMC Clin Pathol 3(1):5
15. Flucke U, Steinborn E, Dries V, Monig SP, Schneider PM, Thiele J, Holscher AH, Dienes HP, Baldus SE (2003) Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.Histopathology 43(2):127-134
16. DeMeester SR, Wickramasinghe KS, Lord RV, Friedman A, Balaji NS, Chandrasoma PT, Hagen JA, Peters JH, DeMeester TR (2002) Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 97(10):2514-2523
17. Mohammed IA, Streutker CJ, Riddell RH (2002) Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol 15(6):611-616
18. Jovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P (2002) Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol Histopathol 17(2):445-454
19. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Gramlich TL (2001) The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 38(4):307-311
20. Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD(2001) Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol 25(1):87-94
21. Couvelard A, Cauvin JM, Goldfain D, Rotenberg A, Robaszkiewicz M, Flejou JF, Groupe d'Etude l'Oesophage de Barrett (2001) Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 49(6):761-766
22. El-Zimaity HM, Graham DY (2001) Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol 96(5):1378-1382
23. Gulmann C, Shaqaqi OA, Grace A, Leader M, Patchett S, Butler D, Kay E (2004) Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinalmetaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus. Appl Immunohistochem Mol Morphol 12(2):142-147
24. Schilling D, Spiethoff A, Rosenbaum A, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer MH, Riemann JF (2005) Does cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. Pathol Res Pract 200(11-12):801-805
25. Wallner B, Sylvan A, Janunger KG, Bozoky B, Stenling R (2001) Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance. Scand J Gastroenterol 36(9):910-915
26. Yagi K, Nakamura A, Sekine A (2005) Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients. J Gastroenterol Hepatol 20(6):929-934
27. Yim HJ, Lee SW, Choung RS, Kim YS, Kim JY, Lee HS, Song CW, Choi JH, Bak YT, Ryu HS, Hyun JH, Kim DS, Kim CH (2005) Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barrett's oesophagus in Korea? Eur J Gastroenterol Hepatol 17(6):611-616
28. Shearer C, Going J, Neilson L, Mackay C, Stuart RC (2005) Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease. Histopathology 47(3):268-275
29. Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL (2000) Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 119(3):683-690
30. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS (1997) Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 112(3):760-765
31. Piazuelo MB, Haque S, Delgado A, Du JX, Rodriguez F, Correa P (2004) Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol 17(1):62-74
32. Jaeschke R, Guyatt G, Sackett DL (1994) Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271(5):389-391
33. Zwas F, Shields HM, Doos WG (1986) Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. Gastroenterology 90:1932-1941
34. Glickman JN, Ormsby AH, Gramlich TL, Goldblum JR, Odze RD (2005) Interinstitutional variability and effect of tissue fixative on the interpretation of a Barrett cytokeratin 7/20 immunoreactivity pattern in Barrett esophagus. Hum Pathol 36(1):58-65
35. Kendall C, Stone N, Shepherd N, Geboes K, Warren B, Bennett R, Barr H (2003) Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol 200(5):602-609
36. Krishnadath KK, Reid BJ, Wang KK (2001) Biomarkers in Barrett esophagus. Mayo Clin Proc 76(4):438-446
37. Sauter G, Simon R (2002) Predictive molecular pathology. N Engl J Med 347(25):1995-1996
38. Falk GW (2003) Cytology in Barrett's esophagus. Gastrointest Endosc Clin N Am 13(2):335-348
39. Dalma-Weiszhausz DD, Chicurel ME, Gingeras TR (2002) Microarrays and genetic epidemiology: a multipurpose tool for a multifaceted field. Genet Epidemiol 23(1):4-20
40. Selaru FM, Zou T, Xu Y, et al. (2002) Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 21(3):475-478